nedaplatin

Subscribe to Selected New Research on nedaplatin

201 relevant articles (41 outcomes, 72 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:

(glycolato-O,O')diammineplatinum II; 254-S; CGDP-II; NSC 375101D; NSC-375101D; cis-diammine(glycolato)platinum II

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organometallic Compounds: 5

Organoplatinum Compounds

nedaplatin: 201

Experts

1.	Saito, Haruhiro: 4 articles (08/2008 - 07/2003)
2.	Oshita, Fumihiro: 4 articles (08/2008 - 07/2003)
3.	Yamada, Kouzo: 4 articles (08/2008 - 07/2003)
4.	Tachibana, Hiroyuki: 4 articles (11/2007 - 01/2006)
5.	Fuwa, Nobukazu: 4 articles (11/2007 - 01/2006)
6.	Nemoto, Kenji: 4 articles (01/2007 - 02/2003)
7.	Kodama, J: 3 articles (09/2008 - 03/2001)
8.	Hongo, A: 3 articles (09/2008 - 03/2001)
9.	Noda, Kazumasa: 3 articles (08/2008 - 07/2003)
10.	Horichi, Naoya: 3 articles (04/2008 - 01/2003)

Related Diseases

1.	Neoplasms (Cancer) 06/01/1992 - "Based on these results, it was concluded that 254-S is a very useful anticancer agent for the treatment of cervical cancer." 04/01/2005 - "Doses of nedaplatin (CDGP) were established for concurrent chemoradiation therapy (CCRT) for cervical cancer, and a collaborative dose escalation study involving 8 hospitals was conducted to investigate the safety and efficacy of this therapy" 09/01/2008 - "Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer." 04/01/2005 - "A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer]" 05/01/2004 - "This study was undertaken to evaluate the clinical efficacy and toxicity of Nedaplatin (254-S) alone or combined for UFT for recurrent head and neck cancers in an outpatient setting" Get all the results and reference details, order at left...
2.	Carcinoma (Carcinomatosis) 03/01/2006 - "CONCLUSION: Nedaplatin is effective in the treatment for HNSCC, NSCLC and ovary carcinoma" 01/01/2007 - "In order to evaluate the safety and efficacy of chemoradiotherapy using nedaplatin for locally advanced uterine cervical carcinoma in Japanese patients, we have started a single-institute phase II trial" 12/01/2006 - "This study was to evaluate the efficacy of home-produced Nedaplatin in China on esophageal carcinoma, and observe its toxicity" 01/01/2008 - "Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis." 01/01/2007 - "Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)." Get all the results and reference details, order at left...
3.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/01/2008 - "The purpose of this study was to evaluate the effectiveness and safety of concurrent chemoradiotherapy using weekly nedaplatin for the treatment of locally advanced squamous cell carcinoma of the uterine cervix" 05/01/2007 - "PURPOSE: The present study evaluated the efficacy and safety of nedaplatin-combination therapy (NDP/5-FU [5-FU arm] or NDP/S-1 [S-1 arm] ) for the treatment of oral squamous cell carcinoma" 01/01/2007 - "Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix." 03/01/2002 - "We performed preoperative combined therapy using nedaplatin (CDGP) and radiation in 12 patients with squamous cell carcinoma originating from the oral cavity and maxillary sinus, and examined for any adverse events that may have occurred during this therapeutic regimen" 08/01/2006 - "We report a case of squamous cell carcinoma (SCC) of the bladder treated successfully with intraarterial chemotherapy using nedaplatin" Get all the results and reference details, order at left...
4.	Esophageal Neoplasms (Esophageal Cancer) 02/01/2000 - "The observations suggested that 254-S, which has little or no side effects including nephrotoxicity, can become the standard remedy for esophageal cancer instead of CDDP in future." 10/01/2002 - "Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer]" 09/01/2004 - "This is a report of a case with esophageal cancer in which pathological CR was obtained by neoadjvant chemoradiotherapy using a low-dose of nedaplatin (CDGP)/5-FU" 09/01/2004 - "A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy]" 02/01/1999 - "A 60-year-old male with type 2 advanced esophageal cancer, which was located in the upper part of the esophagus and had invaded adjacent organs, was treated with nedaplatin 150 mg/body (100 mg/m2) given intravenously every 4 weeks from January 6, 1991" Get all the results and reference details, order at left...
5.	Lung Neoplasms (Lung Cancer) 08/01/1993 - "These data suggested the efficacy of 254-S in the treatment of lung cancer." 06/01/1992 - "Based on these results, it was concluded that 254-S is a useful anticancer agent for the treatment of primary lung cancer." 04/01/1993 - "From these results, 254-S may have favorable therapeutic effects on intrathoracic malignancies such as lung cancer and lymph metastasis." 01/01/2001 - "Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer." 06/01/1992 - "A phase II clinical study of 254-S, a new anticancer platinum complex, for primary lung cancer was conducted by the 254-S Lung Cancer Study Group consisting of 15 institutions nation-wide" Get all the results and reference details, order at left...
51 Diseases and 201 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Platinum
3.	Cisplatin (Platino)
4.	Paclitaxel (Taxol)
5.	Ifosfamide
6.	Methotrexate (Mexate)
7.	irinotecan (Camptosar)
8.	gemcitabine
9.	Vincristine (Oncovin)
10.	Cyclophosphamide (Cytoxan)
46 Drugs and Important Bio-Agents and 164 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Combination Drug Therapy (Combination Chemotherapy)
2.	Drug Therapy (Chemotherapy)
3.	Adjuvant Chemotherapy
4.	Brachytherapy
5.	Heterologous Transplantation (Xenotransplantation)
11 Therapies and Procedures and 89 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>